Biohaven Pharmaceutical H...
(BHVN)
undefined
undefined%
At close: undefined
38.47
0.00%
After-hours Dec 13, 2024, 07:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -408.17M | -570.28M | -213.80M | -118.67M | -528.80M | -240.92M | -127.19M |
| Depreciation & Amortization | 6.91M | 1.39M | 1.39M | 72.00K | - | - | - |
| Stock-Based Compensation | 28.79M | 193.56M | 65.64M | 29.50M | 54.97M | 16.93M | 13.24M |
| Other Working Capital | 19.74M | -34.53M | 212.90M | 166.83M | -3.32M | -5.39M | -3.98M |
| Other Non-Cash Items | 16.13M | 106.25M | 4.52M | 4.16M | 93.18M | 21.47M | 15.16M |
| Deferred Income Tax | - | - | -5.26M | - | - | - | - |
| Change in Working Capital | 24.61M | -28.60M | 1.66M | 8.98M | 3.32M | 5.39M | 3.98M |
| Operating Cash Flow | -331.73M | -297.69M | -145.84M | -75.96M | -377.33M | -197.14M | -94.81M |
| Capital Expenditures | -3.05M | -41.07M | -938.00K | -2.70M | -2.53M | -4.17M | -541.00K |
| Acquisitions | - | -35.00M | 1.88M | 267.51M | - | - | - |
| Purchase of Investments | -194.12M | -263.72M | -193.29M | -319.39M | - | -6.38M | -6.63M |
| Sales Maturities Of Investments | 327.00M | - | 221.56M | 94.98M | - | - | - |
| Other Investing Acitivies | - | -4.00M | -28.27M | -43.10M | -1.25M | - | 127.00K |
| Investing Cash Flow | 129.83M | -304.79M | 944.00K | -2.70M | -3.78M | -10.54M | -7.04M |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | -31.32M | 483.79M | 138.45M | 152.24M | 434.59M | 340.46M | 209.76M |
| Financial Cash Flow | 211.91M | 767.60M | 138.45M | 152.24M | 434.59M | 340.46M | 209.76M |
| Net Cash Flow | 9.52M | 165.55M | -6.45M | 73.59M | 53.48M | 132.78M | 107.90M |
| Free Cash Flow | -334.77M | -338.76M | -146.78M | -78.65M | -379.87M | -201.31M | -95.36M |